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Abstract
Background: Corynebacterium diphtheriae, the agent of diphtheria, is a genetically diverse bacterial species.
Although antimicrobial resistance has emerged against several drugs including first-line penicillin, the genomic
determinants and population dynamics of resistance are largely unknown for this neglected human pathogen.
Methods: Here, we analyzed the associations of antimicrobial susceptibility phenotypes, diphtheria toxin
production, and genomic features in C. diphtheriae. We used 247 strains collected over several decades in multiple
world regions, including the 163 clinical isolates collected prospectively from 2008 to 2017 in France mainland and
overseas territories.
Results: Phylogenetic analysis revealed multiple deep-branching sublineages, grouped into a Mitis lineage strongly
associated with diphtheria toxin production and a largely toxin gene-negative Gravis lineage with few toxin-
producing isolates including the 1990s ex-Soviet Union outbreak strain. The distribution of susceptibility phenotypes
allowed proposing ecological cutoffs for most of the 19 agents tested, thereby defining acquired antimicrobial
resistance. Penicillin resistance was found in 17.2% of prospective isolates. Seventeen (10.4%) prospective isolates
were multidrug-resistant (≥ 3 antimicrobial categories), including four isolates resistant to penicillin and macrolides.
Homologous recombination was frequent (r/m = 5), and horizontal gene transfer contributed to the emergence of
antimicrobial resistance in multiple sublineages. Genome-wide association mapping uncovered genetic factors of
resistance, including an accessory penicillin-binding protein (PBP2m) located in diverse genomic contexts. Gene
pbp2m is widespread in other Corynebacterium species, and its expression in C. glutamicum demonstrated its effect
against several beta-lactams. A novel 73-kb C. diphtheriae multiresistance plasmid was discovered.
Conclusions: This work uncovers the dynamics of antimicrobial resistance in C. diphtheriae in the context of phylogenetic
structure, biovar, and diphtheria toxin production and provides a blueprint to analyze re-emerging diphtheria.
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Background
Diphtheria, if untreated, is one of the most severe bac-
terial infections of humans. It typically affects the upper
respiratory tract causing pseudomembrane formation,
sometimes leading to suffocation and death. The infec-
tion can be complicated by systemic symptoms, caused
by the diphtheria toxin. Other forms of disease are skin
and invasive infections, including endocarditis [1, 2].
The agent of diphtheria is Corynebacterium diphther-
iae, a member of the phylum Actinomycetes [3, 4]. The
diphtheria toxin, encoded by the tox gene, is carried by
lysogenized corynephages within the chromosome of
some C. diphtheriae strains [5, 6]. Concern exists about
the possibility of lysogenic conversion of previously non-
toxigenic strains during colonization, infection, or trans-
mission chains [7]. However, knowledge on the microevo-
lutionary dynamics between tox-positive and tox-negative
strains is limited. The high genetic diversity of C.
diphtheriae strains underlies their variable colonization,
adhesion, and pathogenicity properties [8–10]. Although
three main biovars (Mitis, Gravis, and Belfanti) are distin-
guished since the 1950s, their phylogenetic relationships
are poorly defined [11–13].
Diphtheria used to be one of the deadliest infections
in young children but has been largely controlled by vac-
cination with the highly effective toxoid vaccine [14].
Even so, thousands of cases of diphtheria are still re-
ported annually [15], and large outbreaks can quickly
follow the disruption of public health systems [14, 16–18].
In countries with high vaccination coverage, diphtheria
cases are associated with travel and migration from en-
demic regions [19–21]. As diphtheria vaccination is per-
formed using an inactivated form of diphtheria toxin, it is
not considered to prevent asymptomatic colonization and
silent transmission of the pathogen, which still circulates
and is the object of intense epidemiological surveillance
[4]. However, vaccine preparations may include other an-
tigens, and the impact of vaccination on C. diphtheriae
evolution deserves further studies [22].
Clinical management of infections with toxigenic
isolates includes treatment with diphtheria antitoxin
(DAT), which can prevent or reduce the systemic effects
of the toxin [4]. Nevertheless, antimicrobial treatment is
critical in the clinical management of both tox-positive
and tox-negative infections, as it contributes to the elim-
ination of the bacteria within the patient and limits
transmission to novel individuals [23]. With DAT pro-
duction being threatened [24], antimicrobial treatment
might become even more critical in diphtheria therapy.
Penicillin is the first-line therapeutics to treat diphtheria,
with erythromycin being recommended in case of allergy
[25]. Both antimicrobial agents are generally effective for
the treatment of diphtheria [23, 26]. However, reduced
susceptibility or full resistance of C. diphtheriae to
penicillin, erythromycin, and other antimicrobial agents,
sometimes combined in multidrug-resistant strains, has
been reported from multiple world regions [23, 26–35].
Antimicrobial resistance genes have been described in
C. diphtheriae, including the erythromycin resistance
gene ermX on plasmid pNG2 [36] and genes dfrA16,
qacH, and sul1 carried on a class 1 integron, mobilized
by IS6100 [37]. However, the prevalence and phylogenetic
distribution of resistance genes in C. diphtheriae clinical
isolates are unknown. Six chromosomal penicillin-binding
proteins (PBPs) have been reported in C. diphtheriae [38],
but so far, no association between pbp or other genetic
variation and penicillin resistance has been described. Un-
derstanding the genetic basis of antimicrobial resistance in
C. diphtheriae would improve our ability to diagnose and
track its spread.
The aims of this study were (i) to characterize anti-
microbial resistance phenotypes in a large collection of
C. diphtheriae strains with diverse geographical and
temporal origins and to uncover genomic determinants
of resistance and (ii) to analyze the population structure
of C. diphtheriae and define the associations between
antimicrobial resistance, diphtheria toxin production,
biovars, and phylogenetic sublineages.
Methods
Corynebacterium diphtheriae isolates and strains
A collection of 247 C. diphtheriae isolates were included
(Additional file 1: Table S1), corresponding to three sub-
sets. First, we included 163 clinical isolates (recent clin-
ical isolates subset, Additional file 1: Table S1) collected
prospectively between 2008 and 2017 by the French
National Reference Center for Corynebacteria of the
Corynebacterium diphtheriae complex (NRC-CCD).
These isolates represented all isolates received at the
NRC-CCD that corresponded to the C. diphtheriae spe-
cies (C. belfantii, C. ulcerans, C. pseudotuberculosis, or
other corynebacteria were excluded). They were col-
lected from cutaneous (n = 136), respiratory (n = 23), and
other (bones, blood; n = 4) infections. Of these, 74 were
from Mainland France and 89 from French overseas ter-
ritories, including Mayotte (n = 50), New Caledonia (n =
19), La Réunion Island (n = 11), French Guiana (n = 4),
French Polynesia (n = 3), and Guadeloupe (n = 1); one
isolate received from Institut Pasteur in Madagascar was
also included (Fig. 1). Four isolates from New Caledonia
collected between 2002 and 2006 (02-0322, 02-0338, 03-
1641, and 06-1569) were included in a previous study
[39]; the trimethoprim- and sulfamethoxazole-resistant
isolate FRC0024 was previously shown to harbor an inte-
gron with gene drfA16 [37].
Second, we included 15 clinical isolates collected in
France between 1981 and 1991, 11 of which had been
deposited in the Collection de l’Institut Pasteur (CIP;
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A. Strains per year and resistance phenotypes origins
B. Geographic origins 
Fig. 1 Temporal and geographical distribution of strains studied. a The number of strains per year, 1945–2017. The 2008–2017 clinical isolates are
represented in red- or yellow-shaded patterns (see key), whereas the older clinical isolates are in gray and the reference strains in blue. The inset
shows the pie charts with the frequency of resistance phenotypes among strains from the four most represented geographic origins; the
remaining ones are pooled in the right-most pie chart. b Geographic origins of strains from the three subsets
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historical clinical isolates subset in Additional file 1:
Table S1).
Third, to increase the genetic diversity and geographic
range of the sample, the 65 available reference strains of
ribotypes that belong to C. diphtheriae were included
[40]. These reference strains represent an international
collection of isolates collected over several decades and
originating from multiple world regions including the
Americas, Europe, Asia, Africa, and Oceania. Our sub-
cultures of these strains were controlled for tox gene
presence, toxin production, and biovar, leading to modi-
fications of published characteristics in some instances
(Additional file 1: Table S1; Fig. 1). Finally, four refer-
ence strains were included: strain NCTC13129, which is
used as genomic sequence reference [38]; strain
NCTC10648, which is used as the tox-positive and toxi-
nogenic reference strain in PCR and Elek tests, respect-
ively; strain NCTC11397T, which is the taxonomic type
strain of the C. diphtheriae species; and the vaccine pro-
duction strain PW8, which corresponds to CIP A102
[41]. This third subset is referred to as “ribotype and ref-
erence strains” subset (Additional file 1: Table S1).
Bacterial cultures, identification, and biovar
Bacteria were cultivated on Trypto-Casein-Soy (TCS)
agar for 24 h at 35–37 °C. Bacterial identification was
performed at the NRC-CCD as described previously [42]
by multiplex polymerase chain reaction (PCR) combin-
ing a dtxR gene fragment specific for C. diphtheriae and
a multiplex PCR that targets a fragment of the pld gene
specific for C. pseudotuberculosis, the gene rpoB (ampli-
fied in all species of the C. diphtheriae complex) and a
fragment of 16S rRNA gene specific for C. pseudotuber-
culosis and C. ulcerans, respectively. Isolates collected
since 2014 were confirmed as C. diphtheriae by matrix-
assisted laser desorption-ionization time-of-flight mass
spectrometry (MALDI-TOF MS) using Bruker technol-
ogy. In order to exclude strains initially identified as C.
diphtheriae but now classified as C. belfantii [42] or C.
rouxii [43], genome-wide average nucleotide identity
(ANI) was used as described previously [42]. Strains
were characterized biochemically for pyrazinamidase,
urease, and nitrate reductase and for utilization of mal-
tose and trehalose using API Coryne strips (BioMérieux,
Marcy l’Etoile, France) and the Rosco Diagnostica re-
agents (Eurobio, Les Ulis, France). The Hiss serum water
test was used for glycogen fermentation. The biovar of
isolates was determined based on the combination of ni-
trate reductase (positive in Mitis and Gravis, negative in
Belfanti) and glycogen fermentation (positive in Gravis
only). The rare biovar Intermedius was not identified, as
its distinction from other biovars is based on colony
morphology, which is considered subjective, or on
lipophily, which was not tested.
Determination of the presence of the tox gene
Determination of the diphtheria toxin gene (tox gene)
presence was achieved by a conventional tox PCR assay
[44], while its phenotypic production was assessed by
the modified Elek test [45]. We also confirmed tox PCR
results by BLASTN (query: tox gene sequence from
strain NCTC13129, RefSeq accession number: DIP_
RS12515) analysis of the genomic assemblies.
Antimicrobial susceptibility testing
Phenotypic susceptibility was tested for the following
agents: penicillin G (10 IU), amoxicillin, oxacillin, cefotax-
ime, imipenem, erythromycin, azithromycin, clarithromy-
cin, spiramycin, pristinamycin, kanamycin, gentamicin,
rifampicin, tetracycline, ciprofloxacin, clindamycin, sulfona-
mide, trimethoprim, and trimethoprim + sulfamethoxazole.
The 19 antimicrobial agents tested (Table S1) corresponded
to seven classes, as described hereafter: β-lactams: penicillin
G (PEN), amoxicillin (AMX), oxacillin (OXA), cefotaxime
(CFT), imipenem (IMP); macrolides: azithromycin (AZM),
clarithromycin (CLR), erythromycin (ERT), and spiramycin
(SPR); lincosamides: clindamycin (CLD); streptogramins:
pristinamycin (PRT); aminoglycosides: gentamicin (GEN)
and kanamycin (KAN); folate pathway inhibitors: sulfona-
mide (SUL), trimethoprim (TMP), and trimethoprim +
sulfamethoxazole (cotrimoxazole, TMP-STX); ansamycins:
rifampicin (RIF); tetracyclines: tetracycline (TET); and
fluoroquinolones: ciprofloxacin (CIP).
Antimicrobial susceptibility was determined using the
disk diffusion method with impregnated paper disks
(Bio-Rad, Marnes-la-Coquette, France) on Mueller Hin-
ton agar plates supplemented with 5% of sheep blood
and 20mg/L β-NAD, as recommended. Minimum in-
hibitory concentrations (MICs) were determined using
E-test strips (BioMerieux, Marcy l’Etoile, France). The
control strain used is Streptococcus pneumoniae ATCC
49619. The zone diameter (ZD) data were interpreted
into S, I, and R categories in the following way. First, we
used the CA-SFM/EUCAST V.1.0 (January 2019) docu-
ment (https://www.sfm-microbiologie.org/wp-content/
uploads/2019/02/CASFM2019_V1.0.pdf), which contains
interpretative criteria for Corynebacterium spp. only for
CIP, GEN, CLD, TET, RIF, and TMP-STX. Second, for
the other agents, we used the interpretative criteria pub-
lished in Table III of the CA-SFM 2013 recommenda-
tions (https://resapath.anses.fr/resapath_uploadfiles/files/
Documents/2013_CASFM.pdf). Note that for RIF, we
used the 2013 breakpoints, as they fitted better with the
observed distribution of ZD values. Clarithromycin
breakpoints were taken from those for erythromycin,
as recommended. The breakpoint for oxacillin was
derived from the one used for Staphylococcus spp. ZD
interpretation breakpoints are given in Additional file 1:
Table S2.
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Penicillin susceptibility was initially determined using
10-UI (6 μg) disks (resistance breakpoint, 18 mm), but
CA-SFM/EUCAST recommendations were changed in
2014 to use 1-UI disks, while the resistance breakpoint
was increased from 18 to 29 mm. As all C. diphtheriae
strains end up in the resistant category following this
recommendation, E-test strips were used to define the
penicillin MIC since 2014 (Additional file 1: Table S2:
isolates starting from FRC0259); the EUCAST break-
point of 0.125 g/L was used as a cutoff. Penicillin E-test
was also performed systematically for strains tested as
resistant before 2014 (using 10-UI disks), as well as for
some susceptible isolates (Additional file 1: Table S1).
Multidrug-resistant C. diphtheriae (MDR-DIP) were
defined as strains resistant to three or more antimicro-
bial agent categories (defined in Additional file 1: Table
S2), excluding intrinsic resistance to fosfomycin [46].
Note that we used ecological cutoffs rather than cur-
rently proposed clinical breakpoints (see Additional file 1:
Table S2 for a comparison of both types of breakpoints).
Whole-genome sequencing by Illumina and Oxford
Nanopore Technologies
DNA was extracted from broth cultures, by making use
of DNeasy Blood & Tissue Kit (QIAGEN, Hilden,
Germany). However, a lysis step was added to the ex-
traction protocol described by the manufacturer as pre-
viously described [47]: a 1-μL loopful of bacterial
colonies was emulsified in 180 μL of lysis buffer contain-
ing 20 mM Tris-HCl, pH 8, 2 mM EDTA, 1.2% Triton
X-100, and 20mg/mL lysozyme, in a DNase/RNase-free
1.5-mL Eppendorf tube and incubated in a heating block
at 37 °C for 1 h, with mixing every 20 min. After extrac-
tion, DNA concentration was measured with the Qubit
3.0 Fluorometer (Invitrogen), employing the Qubit
dsDNA BR Assay Kit (Invitrogen). Besides, the DNA
quality was verified using a D-One spectrophotometer
(Nanodrop). Multiplexed paired-end libraries (2 × 150
bp) were prepared using the Nextera XT DNA kit (Illu-
mina, San Diego, CA, USA) and eventually sequenced
with an Illumina NextSeq-500 instrument at a minimum
of 50× coverage depth. Trimming and clipping were per-
formed using AlienTrimmer v0.4.0 [48]. Redundant or
over-represented reads were reduced using the khmer
software package v1.3 [49]. Finally, sequencing errors
were corrected using Musket v1.1 [50]. A de novo as-
sembly was performed for each strain using SPAdes
v3.12.0 [51]. The genomic sequences of the four refer-
ence strains were retrieved from public repositories
(Additional file 1: Table S1).
Additionally, the multidrug-resistant isolate FRC0402
was subjected to long-read sequencing using Oxford
Nanopore Technologies (ONT). Genomic DNA was ex-
tracted using the phenol-chloroform protocol combined
with Phase Lock Gel tubes (Qiagen GmbH). Libraries
were prepared using a 1D ligation sequencing kit (SQK-
LSK-108) without fragmentation and sequenced using a
MinION FLO-MIN-106 flow cell. Finally, ONT and
Illumina short reads were combined to generate a hybrid
assembly using Unicycler v0.4.4 (normal assembly mode,
default parameters).
Phylogeny, recombination, and genomic sequence
analyses
We built a core genome multiple sequence alignment
(cg-MSA) from the assembled genome sequences. For
this, the genome sequences were annotated using
PROKKA v1.14.2 [52] with default parameters, resulting
in GFF files. Roary v3.6 [53] was used to define protein-
coding gene clusters, with a threshold set at 70% amino
acid identity. Core genes were defined as being present
in 95% of genomes and were concatenated into a cg-
MSA by Roary. ClonalFrameML v1.11 [54] was used to
build a phylogenetic tree based on the cg-MSA, which
quantifies and accounts for the effects of recombination
events. PhyML v20131022 [55] was used to build an ini-
tial tree. To evaluate bootstrap support, IQtree version 2
[56] with best-fit model GTR+F+R10 was used.
We used Kleborate v1.0.0-beta (https://github.com/
katholt/Kleborate), with the --resistance option, to iden-
tify (identity > 80% and coverage > 90%) known resist-
ance genes in C. diphtheriae genomic sequences, based
on the August 1, 2019, update of the ARG-Annot data-
base. We used BLASTN (identity > 80% and coverage >
95%) to search for the presence of the tox gene and of
genes associated with biovar Gravis (DIP351, DIP354,
and DIP357) and for nitrate utilization (narKGHJI).
MLST genotypes were defined using the international
MLST scheme for C. diphtheriae and C. ulcerans [12].
Genome-wide association studies
The software treeWAS [57] was used to find genome-
wide associations between either antimicrobial resistance
phenotypes or biovar on the one hand and genetic vari-
ants (both core-genome SNPs and accessory genome
gene presence/absence) on the other hand. Core-
genome SNPs were derived either from a mapping ap-
proach (Samtools v1.9 and GATK v3.4-0), which com-
prises intergenic regions, or from the alignment of core
coding sequences found using Roary. We ran treeWAS
v1.1 with default parameters, using as input the previ-
ously computed ClonalFrameML phylogenetic tree and
distribution of homoplasies, in order to account for both
the population structure and effect of recombination.
For this analysis, susceptibility phenotypes were classi-
fied into resistant or susceptible categories based on
zone diameter phenotypes using the CA-SFM/EUCAST
2019 cutoffs (Fig. 3, Additional file 3: Table S3). The
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seven chromosomal PBP coding sequences (including
gene with locus tag RS14485 in RefSeq NC_002935.2, or
DIP0637 in the original GenBank file, renamed by us as
PBP4b) were extracted from the genomic sequences and
translated into amino acid (AA) sequences, which were
also analyzed for association with penicillin resistance.
Cloning and transformation experiments
For ectopic expression in C. glutamicum, the pbp2m
gene was amplified from C. diphtheriae strain FRC0402
and put under the control of the inducible PgntK pro-
moter on the shuttle vector pTGR5 [58] (Additional file 4:
Fig. S1). pbp2m was assembled in this plasmid by Gibson
assembly using the primers PBPdi_Fw (CAA AGA AAG
GAT AAG ACC ATA TGA TGA CTA AGC ACA ATC
GTT TCC GTC), PBPdi_Rv (TAC CTT AAG CGG
CCG CTT TAT TGA ATT CCA GAG AAT TTC TGA
ACA TCC G), pTGRdi_Fw (TAA AGC GGC CGC TTA
AGG TAC C), and pTGRdi_Rv (ATG GTC TTA TCC
TTT CTT TGG TGG CG).
Escherichia coli CopyCutter EPI400 (Lucigen) was
used for the cloning of the pbp2m gene and was grown
in Luria-Bertani (LB) broth or agar plates at 37 °C sup-
plemented with 50 μg/mL kanamycin. The pTGR5_
pbp2m plasmid was sequenced and electroporated into
Corynebacterium glutamicum ATCC 13032. Positive col-
onies were grown in brain heart infusion (BHI) at 30 °C
and 120 rpm supplemented with 25 μg/mL kanamycin
and 1% (w/v) gluconate when required for ectopic ex-
pression of Pbp2m.
Mapping of SNPs on C. diphtheriae PBP sequences
Functional annotation of the different sequences was
performed with InterPro [59]. Conserved transpeptida-
tion motifs SxxK, SxN, and KTG were identified and
mapped on the PBP sequences from Corynebacteriales
based on the results of multiple sequence alignments
performed with Clustal Omega [60]. When uncertainty
between a transmembrane domain and a signal peptide
existed, a decision was made based on the previous
characterization of the homologous PBP in other Cory-
nebacteriales in the literature.
Results
Provenance and microbiological characteristics of C.
diphtheriae isolates
We studied 247 C. diphtheriae strains of diverse geo-
graphic and temporal origins (Fig. 1). This collection in-
cluded 163 isolates prospectively collected between 2008
and 2017 from French mainland and overseas territories,
15 older (1981–2006) French clinical isolates, 65 ribo-
type reference strains [40], and 4 other reference strains.
All isolates were confirmed as C. diphtheriae (excluding
C. belfantii and C. rouxii) based on an average
nucleotide identity (ANI) value higher than 96% with
the C. diphtheriae type strain NCTC11397T.
Approximately one third (n = 78, 32%) of isolates were
tox-positive (as defined by the detection of the tox gene
by PCR), whereas the remaining 169 isolates (68%) were
tox-negative. The proportions of tox-positive isolates
were 42%, 34%, and 2% among reference strains, 2008–
2017 clinical isolates, and older clinical isolates, respect-
ively (Additional file 4: Fig. S2). Of the 78 tox-positive iso-
lates, 17 (21.8%) were negative for toxin production and
thus correspond to non-toxigenic toxin gene-bearing
(NTTB) isolates. Six of the NTTB isolates had a stop
codon within the tox gene sequence (Additional file 1:
Table S1, Additional file 5: Table S4). However, for the 11
remaining strains, we found no explanation for the ob-
served lack of toxin production.
Upon biotyping, 154 (62.3%) isolates belonged to bio-
var Mitis, 87 to biovar Gravis (35.2%), and 6 (2.4%) to
biovar Belfanti (Additional file 1: Table S1). Biovar pro-
portions were similar among the three datasets. Mitis
isolates were more frequently tox-positive than Gravis
isolates (56/154 versus 18/87, chi-squared test, p value
0.01; Additional file 4: Fig. S2). Among tox-positive iso-
lates, NTTB were more frequent among Mitis isolates
(13/56, 23.2%) than among Gravis isolates (1/18, 5.6%)
although this difference was not statistically significant
(p value 0.09). Three out of four tox-positive Belfanti iso-
lates were NTTB.
Phylogenetic structure of C. diphtheriae and distribution
of the toxin gene
To infer a phylogenetic tree, we first aimed to detect
and remove homologous recombination events among
C. diphtheriae genomic sequences. ClonalFrameML in-
ferred a relative rate of recombination to mutation (R/
theta) of 0.86, with an average length of recombination
segments (delta) of 287 bp. The mean genetic distance
between donor and recipient of recombination (nu) was
estimated by ClonalFrameML to be 0.02, resulting in a
relative impact of recombination to mutation in genomic
diversification (r/m = R/theta × delta × nu) of 5.01 [61].
The recombination-corrected phylogeny was similar to
the uncorrected phylogeny but with shorter branches, as
expected (Additional file 4: Fig. S3). The phylogeny,
rooted with C. belfantii and C. rouxii (Additional file 4:
Fig. S4), was star-like, with a multitude of sublineages
branching off deeply. The deepest branching sublineages
corresponded to two ribotype reference strains of biovar
Mitis: CIP107521 (ribotype Dagestan) and CIP107534
(ribotype Kaliningrad). Remarkably, isolates of biovars
Mitis and Gravis were mostly distributed in two distinct
branches of the tree. We therefore named the two major
branches, lineage Mitis (156 strains, of which 86% were
of biovar Mitis) and lineage Gravis (91 strains, of which
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77% were of biovar Gravis). The Gravis lineage branched
off from within the Mitis lineage (Fig. 2; Additional file 4:
Fig. S5). However, although most shallow branches were
strongly supported, bootstrap support values of the deep
nodes of the phylogeny were generally weak, implying
that the position of the Gravis branch within the Mitis
diversity was uncertain, as were the relative positions of
the early-branching Gravis and Mitis sublineages (Add-
itional file 4: Fig. S5, Fig. S6). Reference strains PW8 and
NCTC11297T belonged to the Mitis lineage, whereas
NCTC13129 (from the ex-Soviet Union 1990’s outbreak)
and NCTC10648 belonged to the Gravis lineage. The
Belfanti isolates were scattered in three distinct subli-
neages within the Mitis lineage and one within the
Gravis lineage.
The isolates carrying the tox gene belonged mostly to
the Mitis lineage (68 of 78, 87.2%), in which they were
distributed in multiple sublineages. In the Mitis lineage,
69 (44.2%) were tox-positive. In contrast, within the
Gravis lineage, only 10 (11%) isolates were tox-positive,
and they corresponded to the earliest-branching Gravis
sublineages with only one exception. Interestingly, this
exception corresponded to the large ex-Soviet Union
outbreak in the 1990s ((Fig. 2; Additional file 4: Fig. S5).
This phylogenetic pattern is consistent with an evolu-
tionary scenario where Mitis is the ancestral biovar of C.
diphtheriae and where Gravis evolved from the Mitis
lineage as an initially tox-positive sublineage, with subse-
quent loss of the toxin gene. In this scenario, the ex-
Soviet Union outbreak sublineage would have re-
acquired the tox gene. All NTTB isolates belonged to
the Mitis lineage except strain CIPA99 (ribotype Rhone,
biovar Belfanti; Fig. 2), and they were distributed in mul-
tiple sublineages, showing convergent evolution towards
the loss of toxin production.
Genetic events linked to biovar status
Biovar Mitis and Gravis are distinguished by the ability
to utilize glycogen (positive in Gravis, negative in Mitis).
The spuA gene, which codes for a putative alpha-1,6-gly-
cosidase, was reported as being specific for biovar Gravis
isolates [62]. Our genome-wide association study (GWAS)
of accessory genes with the biovar phenotype revealed a
strong association of a cluster of genes that includes spuA
(DIP357; Additional file 4: Fig. S7) with biovar Gravis iso-
lates, providing statistical support to the discovery of San-
tos et al. [62]. This association was stronger within the
Gravis lineage; in contrast within the Mitis lineage, few (5
out of 17) of the biovar Gravis isolates possessed spuA
(Fig. 2). GWAS analysis of core SNPs further demon-
strated that a SNP (at position 324,487, Additional file 4:
Fig. S7) downstream of the spuA cluster insertion point
was also associated with biovar, suggesting homologous
recombination among core genes as a mechanism for the
spuA cluster insertion event.
The nitrate reductase activity differentiates Mitis and
Gravis isolates, which are positive, from Belfanti isolates,
which are nitrate-negative. We found that the nitrate re-
duction narKGHJI gene cluster [62] was disrupted in
three of the six isolates assigned to the biovar Belfanti:
strains FRC0480 and FRC0481 had a G to A mutation at
position 675 of the narG gene, leading to a stop codon,
whereas in strain CIPA99, approximately 100 nucleo-
tides were inserted at position 446 in narG. No molecu-
lar explanation was found for the lack of nitrate
reductase ability of the three other Belfanti strains when
scrutinizing the narKGHJI gene cluster and adjacent mo-
lybdenum cofactor biosynthesis genes [63].
Antimicrobial susceptibility variation
Susceptibility to 19 antimicrobial agents was determined
for the 247 clinical isolates and reference strains (Add-
itional file 3: Table S3). For each agent, the distribution of
zone diameter (ZD) values (Fig. 3) revealed a predominant
mode located towards the right end of the distribution.
This mode likely corresponds to the natural susceptibility
distribution within the C. diphtheriae population and was
used to define tentative epidemiological cutoffs (ECOFFs,
also called ecological cutoff [64]). The proposed ECOFFs
and their comparison with clinical breakpoints are pre-
sented in Additional file 2: Table S2. For each antimicro-
bial agent except cefotaxime, this approach led to the
identification of strains that had ZD values smaller than
those in the main mode, thus potentially corresponding to
acquired resistance (Fig. 3).
Penicillin was exceptional in that the predominant
mode (centered around 36 mm) was less neatly defined,
due to the partial overlap with a second mode of smaller
diameter values centered around 24mm. This second
mode corresponds mostly to the “intermediate” inter-
pretative category (18 ≤ ZD < 29 mm) but also overlaps
with the “resistant” category (< 18mm). The distribution
of ZD values for tetracycline also showed a clear second
mode. For multiple other agents (amoxicillin, oxacillin,
imipenem, kanamycin, rifampicin, ciprofloxacin, clinda-
mycin and more evidently sulfonamide, trimethoprim,
and the trimethoprim-sulfamethoxazole combination),
some strains had the minimal diameter (6 mm, corre-
sponding to growth at the disk contact). For trimetho-
prim, we observed both a second mode centered around
14mm and a group of even more resistant strains with
growth at disk contact.
Antimicrobial resistance levels were similarly distrib-
uted between tox-positive and tox-negative isolates
(Additional file 4: Fig. S8) as well as between the two
main phylogenetic lineages or biovars (Additional file 4:
Fig. S9; Additional file 1: Table S1). In particular, the
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Fig. 2 Phylogenetic tree of C. diphtheriae. The tree was obtained using ClonalFrameML and was rooted using C. rouxii and C. belfantii isolates (see
supplementary material). The main lineages Mitis and Gravis are labeled, and their branches are drawn using purple and green, respectively. The
first (internal) circle around the tree corresponds to the three strain subsets (red, recent clinical isolates; blue, reference strains; gray, older clinical
isolates). The second circle (stars) gives the toxigenic status. The third circle corresponds to biovars Mitis (purple), Gravis (green), and Belfanti
(yellow). The next three circles indicate the presence of the spuA-associated gene cluster; DIP357 = spuA gene. The positions of reference strains
PW8, NCTC13129, and NCTC10648 are indicated. The scale bar gives the number of nucleotide substitutions per site
Hennart et al. Genome Medicine          (2020) 12:107 Page 8 of 18
proportion of multidrug-resistant strains was not statisti-
cally different between biovars Mitis (n = 14) and Gravis
(n = 4; chi-square test p value 0.2) or between tox-posi-
tive and tox-negative isolates (6 versus 12, p value 0.87).
Resistance rates were 17.2%, 2.5%, and 2.5% for peni-
cillin, amoxicillin, and erythromycin, respectively, among
the prospectively collected 2008–2017 clinical isolates
(Fig. 4). Reference strains were generally susceptible to
most agents, including penicillin, but were partially re-
sistant to tetracycline (18%) and sulfonamide (35%). The
resistance profile distribution showed that approximately
half (121/247) of the strains had a fully susceptible
phenotype, whereas 18 isolates (7.3%) were multidrug-
resistant (Table S1). Notably, four isolates were resistant
at the same time to penicillin and macrolides (Fig. 4
inset), and two of them (FRC0402 and FRC0466) add-
itionally had a reduced susceptibility to amoxicillin. Two
of these isolates (FRC0475 and FRC0478) were collected
from a foot arch wound and in respiratory carriage in
the same patient (French mainland, with recent travel
from New Caledonia). The two others came from a
patient living in La Réunion Island (FRC0402) and from
a patient living in Paris, who had recently traveled to
Tunisia (FRC0466). Of the 18 multidrug-resistant iso-
lates, 1 was a 1994 isolate from India and 17 belonged to
the 2008–1017 prospective subset of clinical isolates
(representing 10.4% of these). Isolates from La Réunion
Island and mainland France showed resistance to mul-
tiple antimicrobial agents more often than isolates from
other geographic origins (Fig. 1a, inset).
Genomic associations with antimicrobial resistance
phenotypes
We first searched for the presence in the genomic se-
quences, of previously described antimicrobial resistance
genes (ARGs). This approach led to the detection of 12
ARGs (Additional file 6: Table S5). We identified three
tetracycline resistance genes (tetW, tet33, and tetO), four
aminoglycoside resistance genes [aph (3′)-Ia, aph (3″)-Ib,
aph (6)-Id, and aadA1 = ant (3′)-Ia], and also ermX,
dfrA16, dfrA15b, dfrA1, and sul1 genes. We observed a
strong correlation between the presence of ARGs and the
Fig. 3 The distributions of zone diameter values for 19 antimicrobial agents. a Beta-lactams, macrolides, and pristinamycin. b Other agents. X-axis:
diameter in millimeters; Y-axis: number of strains. The colors inside the bars represent the subset and geographic origins as in Fig. 1 (see key on
b). The three background colors represent the categorical interpretations according to EUCAST: resistant (salmon, left), intermediate (lighter
salmon, middle), and susceptible (pale beige, right). The gray vertical bar corresponds to the proposed tentative ecological cutoff
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expected resistance phenotypes (Additional file 4: Fig.
S10), particularly for ermX (macrolide resistance; phi coef-
ficient = 0.66 with erythromycin resistance), sul1 (sulfona-
mide resistance; phi = 0.80), and aph (3′)-Ia (kanamycin
resistance; phi = 0.84). In strains FRC0137 and FRC0375,
this latter gene was linked to aph (3′)-Ib (strA), aph (6)-Id
(strB), and ermX on a Tn5432-like genomic region with
an IS1249 insertion sequence [65]. The phylogenetic dis-
tribution of ARGs (Fig. 5; Additional file 4: Fig. S6) re-
vealed their presence in multiple unrelated sublineages,
consistent with independent acquisitions by horizontal
gene transfer. Gene ermX was present either in proximity
to gene pbp2m (see below) or in a fragmented insertion-
sequence rich accessory region. Gene dfrA16 was associ-
ated with sul1 on a reported [37] class 1 integron (see the
“Discovery of a multidrug-resistant conjugative plasmid
carrying the gene pbp2m” section). Tetracycline resistance
was associated either with the ribosomal protection pro-
tein genes tet(O) or tet(W) or with the efflux pump gene
tet33. These three genes were present in distinct strain
subsets and appear to contribute independently to tetra-
cycline resistance in C. diphtheriae (Fig. 5); they were
mostly associated with insertion sequences but not with
other ARGs.
Next, in order to identify novel genetic determinants
potentially associated with antimicrobial resistance in C.
diphtheriae, a GWAS approach was followed, based on
either core genome SNPs or accessory gene presence/ab-
sence. SNPs that were strongly associated with ciprofloxa-
cin, trimethoprim, and rifampicin resistance were identified
within genes for gyrase subunit A, dihydrofolate reductase,
and RNA polymerase subunit B, respectively (Add-
itional file 6: Table S5; Additional file 4: Fig. S11), consistent
with known mechanisms and validating our approach.
SNPs were also found to be associated with penicillin, kana-
mycin, and tetracycline resistance (Additional file 6: Table
S5), but based on the annotations of the genes where they
are located, the functional implications of these SNPs are
unclear in these cases. No association was found for penicil-
lin resistance within the core PBP genes using the genome-
wide approach. However, using a concatenation of the
amino acid sequences of the seven identified putative PBPs
of C. diphtheriae, we identified amino acid positions that
were statistically associated with penicillin resistance (Add-
itional file 4: Fig. S12). The identified positions were
mapped onto the predicted functional domains of the dif-
ferent PBPs (Additional file 4: Fig. S13) revealing several
mutation hotspots. A number of significant SNPs were
Fig. 4 Proportions of resistant strains by antimicrobial agent and multidrug resistance distribution. Interpretation of the zone diameter values was
performed according to the proposed ecological cutoffs. The main panel shows the percentage of strains resistant to each agent. Tmp-stx,
trimethoprim-sulfamethoxazole. The four bars for each agent correspond to the entire dataset (all, shaded green) or the three subsets (see key).
The inset shows the number of strains resistant to a given number of antimicrobials. Penicillin- and/or erythromycin-resistant strains are colored
with darker green (see key). FRC0402, the most multidrug-resistant isolate with resistance to 12 agents, is highlighted
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Fig. 5 (See legend on next page.)
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found within the transpeptidase (TP) domains of the differ-
ent PBPs, but none of the mutations mapped to the con-
served transpeptidation motif. Other mutations were found
outside the TP domains, for instance, in the transglycosy-
lase and PASTA domains of PBP1b or in the dimerization
domain of PBP2b.
GWAS analysis of accessory genes demonstrated signifi-
cant associations with phenotypic resistance. Associated
genes included those mentioned above for erythromycin,
tetracycline, kanamycin, sulfonamide, and trimethoprim
(Additional file 6: Table S5), showing that these genes are
the main mechanisms of resistance to these antimicrobial
agents in C. diphtheriae populations. In addition, an
accessory penicillin-binding protein gene (which we name
pbp2m) was strongly associated with penicillin resistance.
This gene is described in more detail below.
Discovery of a penicillin-binding protein (PBP2m)
associated with penicillin resistance
The PBP gene pbp2m was observed in 11 isolates, 8 of
which were penicillin resistant with minimum inhibitory
concentrations (MIC) ranging from 0.19 to 1.5 mg/L.
Two of these isolates were also resistant to amoxicillin
and one was in addition resistant to oxacillin
(Additional file 2: Table S2). The phylogenetic distribu-
tion of pbp2m-positive strains was compatible with mul-
tiple independent acquisitions of the gene through
horizontal gene transfer (Fig. 5). Sequence analysis
showed that the newly identified PBP2m is almost iden-
tical (3 differences out of 593 amino acids, 99.5%) to
PBP2c from C. jeikeium, a class B PBP with an N-
terminal signal peptide followed by a lipobox domain
and the C-terminal transpeptidase domain (Add-
itional file 4: Fig. S13). The C. jeikeium PBP2c is a low-
affinity PBP and was associated with beta-lactam resist-
ance in C. jeikeium [66].
To demonstrate the role of PBP2m in penicillin resist-
ance, its gene was PCR amplified from FRC0402 and
cloned into the pTGR5 plasmid (Additional file 4: Fig.
S1). Transformation of the plasmid into C. glutamicum
strain ATCC 13032 raised the MIC for penicillin from
0.125 to 1.5 mg/L, and the MICs of the other beta-
lactams amoxicillin, oxacillin, and cefotaxime also in-
creased importantly (Fig. 6; Additional file 7: Table S6).
In contrast, MICs of non-beta-lactam agents were not
changed. Imipenem was less effective against the trans-
formant based on disk diffusion but not based on E-test.
Transformation with the empty plasmid used as control
(See figure on previous page.)
Fig. 5 Phylogenetic distribution of antimicrobial resistance phenotypes and genes. The phylogenetic tree is the same as in Fig. 1; the Mitis
branch is in purple, the Gravis branch in green. To the right of the tree, each bloc indicates first the phenotype (red, resistant; see key) and
relevant corresponding genotypes (orange, gene or mutation presence)
Fig. 6 Phenotypic effect of pbp2m expression. Compared susceptibility phenotypes for C. glutamicum transformants with plasmid pTGR5
containing, or not, the pbp2m gene. Left, the shift in zone diameter size; right, the shift in the minimum inhibitory concentration (MIC). Diamonds
are positioned on the scales, at positions corresponding to the difference of zone diameters (without pbp2m – with pbp2m) or the log2 of MIC
ratios (with pbp2m/without pbp2m). Red, penicillins or cephalosporins; blue, other agents. Tmp-Stx, trimethoprim-sulfamethoxazole
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did not affect the MIC of any agent. These results show
that PBP2m confers resistance to a broad range of beta-
lactams.
Discovery of a multidrug-resistant conjugative plasmid
carrying the gene pbp2m
Strain FRC0402, a tox-negative isolate from La Réunion
Island, stood out as being resistant to 12 agents (Fig. 4
inset). In addition to pbp2m, this isolate carried genes
sul1, ermX, and dfrA16 and a tetA family tet(Z)-like
(71%) tetracycline efflux gene. To define the genomic
context of resistance genes, a complete genome se-
quence was obtained. The assembly revealed a chromo-
some of 2,397,465 bp and a circular plasmid of 73,763 bp
(Fig. 7), which we propose to name pLRPD (for large re-
sistance plasmid of C. diphtheriae).
The pbp2m gene was located on the large plasmid in a
region comprising three other genes, a blaB beta-
lactamase family gene, a LysR family regulator gene, and
the ermX gene, flanked by two insertion sequences
(IS1628) of the IS6 family (Fig. 7). With disparate direct
repeat sequences, it remains unclear if this region
Fig. 7 Map of plasmid pLRPD from isolate FRC0402. Predicted coding sequences are portrayed by arrows and colored based on the predicted
gene function (refer to key). Inner blue circle, G+C% content; inner green circle, A+T% content. IS3502 annotation is putative; IS3503 is truncated
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represents a single transposable unit or a mosaic of gene
acquisition events in pLRPD. A nearly identical PBP was
observed in 78% of publicly available C. jeikeium ge-
nomes, in 57% of C. striatum genomes and in multiple
other Corynebacterium genomes (Additional file 8: Table
S7). However, the genetic context of PBP2m was highly
variable in C. diphtheriae and among other Corynebac-
terium species (Additional file 4: Fig. S14). A putative
transposable PBP-containing unit (PCU) comprising
genes pbp2m, blaB, and lysR, commonly flanked by
IS3503 (IS256 family) with a fragment identified in
pLRPD (Fig. 7), appeared to be highly conserved and
was associated variably with ermX in C. diphtheriae and
with a helicase in C. diphtheriae and other Corynebac-
terium species. The PCU was sometimes found in 2 or 3
tandem copies and was chromosomally located in most
genomes.
Further elements carried by pLRPD included an inte-
gron carrying genes dfrA16, qacL, and sul1, as well as el-
ements of a putative conjugation apparatus gene cluster
(Fig. 7). Our conjugation experiments aiming to demon-
strate the transfer of pLRPD into recipient C. diphther-
iae isolates failed. This plasmid was not found in other
C. diphtheriae strains.
Discussion
Strains of C. diphtheriae that are resistant to antimicro-
bial therapy may compromise the management of diph-
theria cases and the control of pathogen transmission.
Here, we aimed to define the genomic determinants of
resistance to penicillin and other antimicrobial agents in
C. diphtheriae and to analyze the relationships of resist-
ance with diphtheria toxin production, biochemical vari-
ants, and phylogenetic sublineages. To this aim, we
characterized phenotypically and genotypically a large
sample of C. diphtheriae isolates from diverse geo-
graphic and temporal origins. We confirmed that the
species is made of multiple phylogenetic sublineages [9,
13, 67] and showed that homologous recombination
contributes five times more to their diversification than
mutation, consistent with previous evidence of recom-
bination in C. diphtheriae populations [12, 13].
Historically, C. diphtheriae isolates have been classified
into three main biovars, but the links between biovars
and phylogenetic structure have remained obscure.
Whereas previous work concluded on the absence of an
association [11], our phylogenetic analyses reveal that
Gravis and Mitis, the two main biovars of C. diphtheriae,
are associated strongly with two phylogenetic lineages.
Lineage Gravis appears to have acquired ancestrally a
gene cluster comprising the extracellular glycogen deb-
ranching enzyme gene spuA [62]. Although the Gravis
phenotype was associated with spuA within lineage
Gravis, other genomic determinants of glycogen
utilization remain to be discovered within the Mitis
lineage. Whereas most of our biovar Belfanti isolates
were excluded from this work because they belonged to
C. belfantii or C. rouxii, a few Belfanti isolates did be-
long to C. diphtheriae. For three of them, mutations
leading to a non-functional nitrate reductase were un-
covered, explaining the phenotypic switch to biovar Bel-
fanti. Our results show that biotyping is subject to
parallel evolution, perhaps due to a yet-unknown select-
ive pressure, and has limited species-level identification
(as Belfanti is found in the three species C. diphtheriae,
C. belfantii, and C. rouxii) or epidemiological typing
value.
The most important factor of C. diphtheriae pathogen-
icity is the diphtheria toxin. Despite early realization that
it is encoded on a prophage [5], few studies have investi-
gated the phylogenetic distribution of the tox gene in C.
diphtheriae [8, 9]. Here, we show that tox-positive
strains mainly belong to the Mitis lineage and to early-
diverging branches of the Gravis lineage. The distribu-
tion of tox-positive isolates into multiple Mitis subli-
neages is strongly indicative of independent acquisitions
of the toxin gene. Alternately, this pattern might result
from initial acquisition of the tox gene, followed by sec-
ondary loss in multiple sublineages. The phylogenetic
pattern is also consistent with an ancestral presence of
the tox-bearing phage in the Gravis lineage, with subse-
quent loss of the tox gene in the branch leading to the
ancestor of most Gravis isolates. Future work should in-
vestigate the dynamics of the lysogenic corynephages
and molecular determinants of their sublineage distribu-
tion. One important open question is the likelihood of
tox-negative strains acquiring the tox gene during
colonization, infection, or short-term epidemiological
timeframes [7].
Remarkably, except for early-diverging sublineages,
only one Gravis sublineage was found to carry the tox
gene. This sublineage happens to correspond to the lar-
gest outbreak in recent times, which occurred in Newly
Independent States of the ex-Soviet Union in the 1990s
[13, 14, 38]. This sublineage, which comprises the ST8
reference strain NCTC13129, is genetically distant from
other tox-positive lineages, which belong to the Mitis
lineage. Hence, its antigenic structures or other patho-
genicity properties may have diverged from those of
more common tox-positive isolates, which might have
contributed to its exceptional transmission in the 1990s,
in addition to the decline in vaccine coverage [14]. Of
note, biovar Gravis was named to reflect a perceived
higher severity of infection compared to diphtheria cases
caused by biovar Mitis isolates [68, 69]. Recently, it was
shown that most diphtheria vaccines contain, besides the
anatoxin, multiple other C. diphtheriae immunogens
[22]. The impact of vaccination on the evolution of C.
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diphtheriae populations, and possible variations of cross-
protection as a function of strain diversity, is currently
undefined. This work provides a framework onto which
future studies can build to address this important
question.
Although antimicrobial-resistant C. diphtheriae strains
have been reported on numerous occasions [23, 32],
knowledge on antimicrobial resistance in C. diphtheriae
is largely fragmented and suffers from the lack of
harmonization. Breakpoints used to define resistance
vary according to world region and have changed over
time within single countries [70]. The lack of consensus
on the definition of resistance restricts our ability to de-
fine the magnitude of the problem and its global
significance.
We aimed to define biologically meaningful cutoffs
[64] based on susceptibility phenotype distributions, tak-
ing advantage of our large and diverse sample. Our data
allowed us to propose tentative ecological cutoffs for C.
diphtheriae. This approach should in the future be ex-
tended to MIC values [71] and should use larger and
more diverse strain collections. Nevertheless, our ana-
lyses suggest that non-susceptibility to at least one anti-
microbial agent was acquired by half of C. diphtheriae
strains, regardless of lineage, biovar, or toxigenic status.
This study further suggests that acquired resistance to
penicillin, the first-line therapy against diphtheria, is far
from being rare, affecting > 15% of C. diphtheriae iso-
lates collected in the last decade in France and its
overseas territories. Besides, 10.4% of these isolates were
multidrug-resistant. The high prevalence of resistance to
penicillin, tetracycline, and trimethoprim/sulfamethoxa-
zole found here is consistent with susceptibility surveys
of recent C. diphtheriae isolates in Algeria [29],
Indonesia [31, 72], and India [73]. Many high-income
countries such as France have chosen to use amoxicillin
as the first choice for antibiotic therapy [74], as this mol-
ecule remains highly active. Still, widespread penicillin
resistance is concerning, since diphtheria mainly occurs
in resource-poor settings where penicillin G is largely
used. In contrast, resistance to erythromycin and other
macrolides remains rare. Our results call for concerted
research into the magnitude of the antimicrobial resist-
ance threat in C. diphtheriae.
Knowledge of the genetic mechanisms of antimicrobial
resistance is critical for defining appropriate treatments,
refining diagnostics, and conducting epidemiological
studies of antimicrobial resistance. Resistance genes to
several antimicrobial classes have been described in C.
diphtheriae [36, 37, 75], while additional genes described
in other Corynebacterium species [76] might also be
present in C. diphtheriae. Here, we defined the preva-
lence and phylogenetic distribution of previously re-
ported and newly identified resistance determinants in
C. diphtheriae. We demonstrate the co-occurrence of re-
sistance phenotypes and genes, suggesting a causative
link in multiple instances. We further show that resist-
ance genes have been acquired independently in mul-
tiple sublineages, demonstrating a dynamic resistome in
C. diphtheriae. In addition, we demonstrate an associ-
ation between alterations in chromosomally encoded
targets and phenotypic resistance for quinolone, tri-
methoprim, and rifampicin. Fluoroquinolone resistance
was previously linked to mutations in the gyrA gene in
C. amycolatum [77], C. striatum [78], and C. belfantii
[79] but seemingly never for C. diphtheriae. Finally, we
demonstrate the co-occurrence within some strains of
multiple resistance determinants and uncover a previ-
ously undescribed large resistance plasmid in C.
diphtheriae. The mechanism of genetic transfer of this
plasmid remains to be investigated. This work provides
the first overview of the C. diphtheriae resistome and
will facilitate further studies into the evolutionary emer-
gence of multiresistant C. diphtheriae strains.
Here, we discovered an accessory PBP (PBP2m) and
experimentally showed it to confer resistance to penicillin
and other beta-lactam antimicrobial agents. Its distribu-
tion in multiple sublineages, and its presence in other Cor-
ynebacterium species, clearly demonstrates its horizontal
transfer, and we revealed a multiplicity of genomic con-
texts in which it is found within Corynebacterium. PBP2m
is a putative low-affinity PBP, which would explain why it
is less affected by beta-lactam antibiotics. Very recently,
Forde et al. [80] have reported high-level penicillin resist-
ance (MIC > 256 g/L) in C. diphtheriae strain BQ11 and
have attributed this phenotype to a penicillin-binding pro-
tein located on transposon Tn3503. We found that the
pbp2m-containing unit is 99.92% similar to Tn3503,
which additionally harbors a helicase (Additional file 4:
Fig. S14). Besides, PBP2m is 100% identical to the PBP
from BQ11 and therefore also possesses the V361A alter-
ation (using C. jeikeium as reference) that was hypothe-
sized to confer high-level penicillin resistance [80].
Further studies on the expression of pbp2m in its variable
genetic backgrounds are required to understand the ob-
served difference in penicillin resistance levels. The loca-
tion of pbp2m on a mobile element and its association
with beta-lactam and carbapenem resistance represents a
public health threat.
The seven chromosomal PBPs of C. diphtheriae (in-
cluding the newly annotated PBP4b) were investigated
to identify amino acid sequence polymorphisms associ-
ated with penicillin resistance. Although several alter-
ations were significantly associated, none was directly
implicated with the catalytic residues of the transpepti-
dase or transglycosylase domains. The association with
resistance may not be directly linked to these catalytic
residues but could be due to secondary sites that are
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thought to interfere with beta-lactam ligand binding.
While biochemical and structural studies are necessary
to understand how these mutations affect penicillin sus-
ceptibility, we postulate that some changes in these do-
mains could lead to allosteric effects ultimately resulting
in beta-lactam resistance, as described for Staphylococ-
cus aureus PBP2a [81, 82] or Streptococcus pneumoniae
PBP2x [83]. Other SNPs might simply have been hitch-
hiking due to their physical linkage with functionally im-
portant SNPs [84].
Conclusions
Our phylogenetic analyses showed that C. diphtheriae is
highly diverse and comprises multiple sublineages that
are grouped into two major lineages, characterized by
distinctive associations with biovars Mitis and Gravis
and with the diphtheria toxin gene. Antimicrobial resist-
ance remains rare in France and its overseas territories,
but multidrug-resistant strains were found and have a
wide phylogenetic distribution. Analyses of the genetic
bases of antimicrobial resistance defined the contribu-
tion of previously described mechanisms of resistance
and uncovered a penicillin-binding protein, PBP2m, as-
sociated at the population level with penicillin resistance
and shown experimentally to confer resistance to several
beta-lactam antimicrobial agents. PBP2m is encoded in
diverse genetic contexts, including on a large putatively
conjugative resistance plasmid. This study reveals how
biovars, diphtheria toxin gene, and antimicrobial resist-
ance are associated with the phylogenetic diversity of C.
diphtheriae strains, and provides novel data into the
evolutionary dynamics of these medically important fea-
tures. This framework will facilitate future studies inves-
tigating the emergence of sublineages of C. diphtheriae
involved in diphtheria outbreaks, antimicrobial resistant
infections, and the patterns and drivers of global spread
of C. diphtheriae sublineages.
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